Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
(NASDAQ: TBPH) Delayed: 16.97 +0.41 (2.48%)
Previous Close $16.56    52 Week High $38.92 
Open $16.70    52 Week Low $12.87 
Day High $17.10    P/E N/A 
Day Low $16.64    EPS $0.00 
Volume 676,267